122 related articles for article (PubMed ID: 3286860)
1. Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate.
Duncan GF; Faulkner HC; Farmen RH; Pittman KA
J Pharm Sci; 1988 Mar; 77(3):273-6. PubMed ID: 3286860
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine.
Gaver RC; Deeb G
Cancer Chemother Pharmacol; 1986; 16(3):201-6. PubMed ID: 3516429
[TBL] [Abstract][Full Text] [Related]
3. In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin.
Gaver RC; George AM; Deeb G
Cancer Chemother Pharmacol; 1987; 20(4):271-6. PubMed ID: 3319277
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation.
Yamazaki H; Tanaka K; Gamura S; Hashimoto T; Shimizu M
Drug Metab Pharmacokinet; 2006 Oct; 21(5):429-31. PubMed ID: 17072097
[TBL] [Abstract][Full Text] [Related]
5. Validation of high-performance liquid chromatographic assay methods for the analysis of carboplatin in plasma ultrafiltrate.
Burns RB; Embree L
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):367-76. PubMed ID: 10993526
[TBL] [Abstract][Full Text] [Related]
6. Determination of carboplatin in canine plasma by high-performance liquid chromatography.
Villarino N; Cox S; Yarbrough J; Martín-Jiménez T
Biomed Chromatogr; 2010 Aug; 24(8):908-13. PubMed ID: 20041399
[TBL] [Abstract][Full Text] [Related]
7. Simple and rapid determination of carboplatin in plasma by high-performance liquid chromatography. Error pattern and application to clinical pharmacokinetic studies.
Zufía L; Aldaz A; Castellanos C; Giráldez J
J Chromatogr B Biomed Sci Appl; 2001 Nov; 764(1-2):457-64. PubMed ID: 11817042
[TBL] [Abstract][Full Text] [Related]
8. The disposition of carboplatin in the beagle dog.
Gaver RC; George AM; Duncan GF; Morris AD; Deeb G; Faulkner HC; Farmen RH
Cancer Chemother Pharmacol; 1988; 21(3):197-202. PubMed ID: 3282707
[TBL] [Abstract][Full Text] [Related]
9. Quantification and clinical application of carboplatin in plasma ultrafiltrate.
Downing K; Jensen BP; Grant S; Strother M; George P
J Pharm Biomed Anal; 2017 May; 138():373-377. PubMed ID: 28260690
[TBL] [Abstract][Full Text] [Related]
10. Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry.
Zhang W; Seymour L; Chen EX
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):277-82. PubMed ID: 19026601
[TBL] [Abstract][Full Text] [Related]
11. A full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates.
Ito H; Yamaguchi H; Fujikawa A; Tanaka N; Furugen A; Miyamori K; Takahashi N; Ogura J; Kobayashi M; Yamada T; Mano N; Iseki K
J Pharm Biomed Anal; 2012 Dec; 71():99-103. PubMed ID: 22954448
[TBL] [Abstract][Full Text] [Related]
12. A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates.
Bullen WW; Andress LD; Chang T; Whitfield LR; Welch ML; Newman RA
Cancer Chemother Pharmacol; 1992; 30(3):193-8. PubMed ID: 1628368
[TBL] [Abstract][Full Text] [Related]
13. Specific high-performance liquid chromatographic assay with ultraviolet detection for the determination of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea in plasma.
Supko JG; Phillips LR; Malspeis L
J Chromatogr B Biomed Appl; 1996 Mar; 677(2):351-62. PubMed ID: 8704941
[TBL] [Abstract][Full Text] [Related]
14. Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
Otsuki Y; Kotani A; Kusu F
Chem Pharm Bull (Tokyo); 2012; 60(5):665-9. PubMed ID: 22689405
[TBL] [Abstract][Full Text] [Related]
15. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
Frank SK; Mathiesen DA; Whitfield LR; Ames MM
J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug, fosphenytoin in human plasma and ultrafiltrate.
Cwik MJ; Liang M; Deyo K; Andrews C; Fischer J
J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):407-14. PubMed ID: 9210446
[TBL] [Abstract][Full Text] [Related]
18. Determination of the two diastereoisomers of lobaplatin (D-19466) in plasma ultrafiltrate of cancer patients with a normal or an impaired kidney or liver function by high-performance liquid chromatography with ultraviolet detection.
Welink J; Pechstein B; van der Vijgh WJ
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):107-11. PubMed ID: 8634751
[TBL] [Abstract][Full Text] [Related]
19. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
